CLCF1 Antikörper (AA 29-225)
-
- Target Alle CLCF1 Antikörper anzeigen
- CLCF1 (Cardiotrophin-Like Cytokine Factor 1 (CLCF1))
-
Bindungsspezifität
- AA 29-225
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CLCF1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Mouse monoclonal antibody raised against a full-length recombinant CLCF1.
- Sequenz
- NRTGDPGPGP SIQKTYDLTR YLEHQLRSLA GTYLNYLGPP FNEPDFNPPR LGAETLPRAT VDLEVWRSLN DKLRLTQNYE AYSHLLCYLR GLNRQAATAE LRRSLAHFCT SLQGLLGSIA GVMAALGYPL PQPLPGTEPT WTPGPAHSDF LQKMDDFWLL KELQTWLWRS AKDFNRLKKK MQPPAAAVTL HLGAHGF
- Kreuzreaktivität
- Human
- Immunogen
- CLCF1 (AAH12939, 29 a.a. ~ 225 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- Klon
- 7E10
- Isotyp
- IgM kappa
- Top Product
- Discover our top product CLCF1 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
Product Quality tested by: Antibody Reactive Against Recombinant Protein.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- In ascites fluid
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
- Target
- CLCF1 (Cardiotrophin-Like Cytokine Factor 1 (CLCF1))
- Andere Bezeichnung
- CLCF1 (CLCF1 Produkte)
- Synonyme
- clc antikoerper, nr6 antikoerper, bsf3 antikoerper, nnt1 antikoerper, ciss2 antikoerper, CLCF1 antikoerper, BSF-3 antikoerper, BSF3 antikoerper, CISS2 antikoerper, CLC antikoerper, NNT-1 antikoerper, NNT1 antikoerper, NR6 antikoerper, Bsf3 antikoerper, Clc antikoerper, cardiotrophin like cytokine factor 1 antikoerper, cardiotrophin-like cytokine factor 1 antikoerper, clcf1 antikoerper, CLCF1 antikoerper, Clcf1 antikoerper
- Hintergrund
-
Full Gene Name: cardiotrophin-like cytokine factor 1
Synonyms: BSF3,CISS2,CLC,NNT1,NR6 - Gen-ID
- 23529
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
-